Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.

Woestenberg, Petra J; King, Audrey J; van Benthem, Birgit H B; Donken, Robine; Leussink, Suzan; van der Klis, Fiona R M; de Melker, Hester E; van der Sande, Marianne A B; Hoebe, Christian J P A; Bogaards, Johannes A

Publication

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.

Woestenberg, Petra J; King, Audrey J; van Benthem, Birgit H B; Donken, Robine; Leussink, Suzan; van der Klis, Fiona R M; de Melker, Hester E; van der Sande, Marianne A B; Hoebe, Christian J P A; Bogaards, Johannes A

Type

Article

Language

en

Date

2018-01-04

Show all metadata

Files

jix582.pdf

Adobe PDF, 201.3 KB

Title

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.

Published in

J Infect Dis 2018; 217(2):213-22

Abstract

Observational postmarketing studies are important to assess vaccine effectiveness (VE). We estimated VE from the bivalent human papillomavirus (HPV) vaccine against HPV positivity of vaccine and nonvaccine types in a high-risk population.

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.

Citations

Series / Report no.

Open Access

Type

Language

Date

Files

Research Projects

Organizational Units

Journal Issue

Title

Translated Title

Published in

Abstract

Description

Publisher

Sponsors

DOI

PMID

URI

Additional Links

Embedded videos

Collections